Designed to disappear from view
Fully implanted beneath the scalp, with no intended day-to-day visible hardware.
The Brain-State Vital Sign
The brain has vital signs.
It’s time we could see them.
NVT BVS is an investigational, fully implanted sub-scalp EEG system and BCI-AI platform designed to transform real-world brain activity into longitudinal clinical evidence—beginning with epilepsy.
Epilepsy first
Continuous context
Clinician accountable
Conceptual visualization. NVT BVS is under development; commercial-system performance remains to be established.
Epilepsy is the first clinical wedge.
Longitudinal brain-state infrastructure is the platform.
The missing signal
Neurology sees snapshots.
Disease happens continuously.
Clinic visitLife between visitsClinic visit
Today’s blind zone
Symptoms, treatment response, sleep and brain-state change unfold beyond the exam room.
For episodic neurological disease, the most important evidence is often the evidence no one sees.
- 01Patients remember imperfectly.
Diaries are burdensome and events may be missed or misclassified.
- 02Providers treat through uncertainty.
Brief tests cannot represent weeks or months of lived disease.
- 03Payers lack trusted outcomes.
Utilization data describes cost, but not the brain state that preceded it.
NVT BVS
The missing middle
in brain monitoring.
Designed to combine the signal continuity of an implant with a discreet, monitoring-first experience.
Conceptual placementUnder the scalp. Above the skull.
Hair
Scalp
NVT BVS
Skull
Brain
Illustrative anatomy—not to scale. Final device design, placement and procedure remain subject to clinical and regulatory validation.
Designed for the long view
Passive, longitudinal capture aims to reveal patterns that episodic testing cannot.
Monitoring first
A minimally invasive position between external wearables and brain-penetrating interfaces.
External
Wearables
Visible hardware and patient-dependent use can limit longitudinal continuity.
NVT POSITION
Sub-scalp
NVT BVS
Designed for continuous, discreet EEG monitoring without a brain-penetrating electrode.
Brain-interfacing
Invasive BCIs
High-bandwidth therapeutic or functional interfaces with greater procedural complexity.
Brain-State Operating System
From signal
to intelligence.
NVT is developing an evidence infrastructure that converts continuous brain activity into prioritized, explainable clinical context—without replacing clinical judgment.
NVT BVS
Longitudinal sub-scalp EEG
Edge + cloud AI
Quality, events, trends and context
Brain-state graph
Patient-specific longitudinal model
Clinical workspaces
Patient · provider · payer
Human accountable Clinical decisions remain with qualified providers.
Evidence traceable Every alert links back to signal, context and model version.
AI constrained Agents operate within defined permissions and escalation policies.
One signal. Three kinds of value.
Built around the people
who make care work.
01 / PATIENT
Life first.
Monitoring in the background.
NVT BVS is being designed to reduce the daily work of documenting epilepsy while giving your care team a more complete picture of what happens between visits.
- No intended visible external hardware
- Passive monitoring by design
- Simple context capture when it matters
- Clear escalation to your care team
9:41
TODAY
Good morning, Maya.
Your monitoring is running in the background.
ConnectedNVT BVS
Optional context
Anything you want your care team to know?
Illustrative future workflow—not a released application.
02 / CLINICIAN
See who needs you.
Know why.
A longitudinal workspace designed to turn continuous EEG into a concise, reviewable queue—prioritizing change without hiding the supporting signal.
- Patient-specific baseline and trends
- Explainable triage with source evidence
- Medication and symptom context
- Human review and configurable escalation
NVT / EPILEPSY
Attention queue
ILLUSTRATIVE WORKFLOW — NOT PATIENT DATA
JD
Review suggestedChange from personal baseline
Signal + contextML
Stable patternNo material change identified
On trackAR
Context requestedSleep disruption reported
Awaiting inputLongitudinal brain-state timelineSource-linked
Concept interface. Outputs require clinical validation and qualified review.
03 / INVESTOR
A focused wedge.
A compounding data platform.
Epilepsy creates a defined path to validate device safety, signal utility and workflow value. The underlying architecture is intentionally designed for additional brain-state applications.
- Durable longitudinal data asset
- Device + software + services model
- Clinical workflow and evidence moat
- Modular expansion across neurology
NVTBrain-State
Operating System
Operating System
01Continuous signal
02Clinical context
03Validated models
04Better workflows
Start narrow. Build deliberately.
Epilepsy first.
Epilepsy offers a high-need, event-driven indication in which objective longitudinal measurement may change how clinicians characterize disease and assess treatment response.
Measurable episodes
Electrical events create a direct starting point for a brain-state vital sign.
Persistent uncertainty
Clinical decisions often rely on incomplete diaries and short recording windows.
Actionable evidence
Longitudinal patterns may support more informed review of therapy and risk.
CAPTUREReal-world EEG
UNDERSTANDPatient-specific patterns
ACTPrioritized clinical review
PROVEOutcomes and access value
Intentional platform handles
One architecture.
Multiple brain states.
Future applications are research concepts—not validated indications or commercial claims.
Epilepsy
Seizure burden · treatment response
Cognition
Dementia · cognitive change
Mood
Depression · state dynamics
Movement
Parkinson’s · motor states
Sleep
Alertness · architecture
Pain
Migraine · episodic context
Recovery
Neuroplasticity · rehabilitation
Brain injury
Stroke · TBI · concussion
Evidence, clearly staged
Build trust by showing
what is known—and what is next.
NVT’s scientific foundation includes blinded human signal studies and published algorithm work. The complete chronic commercial system still requires prospective clinical and regulatory validation.
PEER-REVIEWED · HUMAN DATA
Sub-scalp signal validation
Blinded analysis comparing sub-scalp recordings with intracranial EEG during clinically observed care.
View on PubMed ↗PEER-REVIEWED · RETROSPECTIVE
Automated ictal detection
A subject-specific algorithm study examining seizure detection from sub-scalp recordings.
View on PubMed ↗THE NVT EVIDENCE LADDER
Claims advance only as evidence advances.
- 01Safety + feasibilityTO VALIDATE
Implant, healing, explant and sustained-use endpoints
- 02Signal + algorithm validityFOUNDATION
Prespecified performance against appropriate reference standards
- 03Clinical utility + workflowTO VALIDATE
Decision impact, review burden and time-to-action
- 04Payer + access valueTO VALIDATE
Utilization, quality-of-life and health-economic outcomes
Built at the intersection
Neurology.
Neurosurgery.
AI + medtech.
NeuroView Technology brings together clinicians who understand the consequences of missing brain-state information and operators who know how to build regulated healthcare technology.
Ruben Kuzniecky, MD
Co-founder · Neurology
Werner Doyle, MD
Co-founder · Neurosurgery
Steven Pacia, MD
Co-founder · Neurology
Daniel Friedman, MD, MSc
Co-founder · Epilepsy
Scott Verner
Leadership · Medtech
Timir Datta-Chaudhuri, BS, MS, PhD
Technology · Bioelectronics
A clearer view of the brain
Make the invisible
clinically useful.
Connect with NVT as a patient advocate, clinical collaborator or strategic partner.